Healthcare Trust of America, Inc. Announces Reactivation of its Share Repurchase Program

Rhea-AI Summary

Healthcare Trust of America (NYSE:HTA) announced the reactivation of its stock repurchase program, allowing for the purchase of up to $300 million of its Class A common stock until September 22, 2023. This plan replaces a previous $300 million program that expired in August 2020. Stock repurchases will depend on market conditions and HTA's capital needs. The company has invested approximately $7.3 billion in medical office buildings across 24.9 million square feet as of June 30, 2020, indicating strong growth potential.

Positive

• Authorized a new stock repurchase program worth $300 million, enhancing shareholder value.
• Continued investment in medical office buildings, totaling $7.3 billion, reflects strong market positioning.

Negative

• None.

SCOTTSDALE, Ariz., Sept. 22, 2020 /PRNewswire/ -- Healthcare Trust of America, Inc. (NYSE:HTA), the largest dedicated owner and operator of medical office buildings in the United States, announced today that its Board of Directors approved the reactivation and extension of its stock repurchase program. Under the reactivated plan, HTA is authorized to purchase up to $300 million of its Class A common stock from time to time prior to September 22, 2023. This plan replaces its previous $300 million share repurchase program that was established in August 2018 and expired in August 2020.

Stock may be repurchased in open market and stock repurchases, and the amount and timing of any repurchase, will be dependent on various factors, including HTA's capital position and needs, market conditions, other capital management objectives and opportunities, and applicable legal requirements.  HTA intends to finance any stock repurchases through available cash and its revolving credit facility.

About HTA

Healthcare Trust of America, Inc. (NYSE: HTA) is the largest dedicated owner and operator of medical office buildings in the United States, comprising approximately 24.9 million square feet of GLA, with $7.3 billion invested primarily in medical office buildings as of June 30, 2020.  HTA provides real estate infrastructure for the integrated delivery of healthcare services in highly-desirable locations.  Investments are targeted to build critical mass in 20 to 25 leading gateway markets that generally have leading university and medical institutions, which translates to superior demographics, high-quality graduates, intellectual talent and job growth.  The strategic markets HTA invests in support a strong, long-term demand for quality medical office space.  HTA utilizes an integrated asset management platform consisting of on-site leasing, property management, engineering and building services, and development capabilities to create complete, state of the art facilities in each market.  This drives efficiencies, strong tenant and health system relationships, and strategic partnerships that result in high levels of tenant retention, rental growth and long-term value creation.  Headquartered in Scottsdale, Arizona, HTA has developed a national brand with dedicated relationships at the local level.

Founded in 2006 and listed on the New York Stock Exchange in 2012, HTA has produced attractive returns for its stockholders that have outperformed the US REIT index.  More information about HTA can be found on the Company's Website (www.htareit.com), Facebook, LinkedIn and Twitter.

Forward-Looking Language

This press release contains certain forward-looking statements.  Forward-looking statements are based on current expectations, plans, estimates, assumptions and beliefs, including expectations, plans, estimates, assumptions and beliefs about HTA, stockholder value and earnings growth.

The forward-looking statements included in this press release are subject to numerous risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements.  Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond HTA's control.  Although HTA believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, HTA's actual results and performance could differ materially and in adverse ways from those set forth in the forward-looking statements.  Factors which could have a material adverse effect on HTA's operations and future prospects include, but are not limited to:

• the Company's ability to effectively deploy proceeds of offerings of securities;
• changes in economic conditions affecting the healthcare property sector, the commercial real estate market and the credit market;
• competition for acquisition and development of medical office buildings and other facilities that serve the healthcare industry;
• the Company's ability to acquire or develop real properties, and to successfully operate those properties once acquired or developed;
• pandemics and other health concerns, and the measures intended to prevent their spread, including the currently ongoing COVID-19 pandemic;
• economic fluctuations in certain states in which the Company's investments are geographically concentrated;
• financial stability and solvency of the Company's tenants, including the ability and willingness of the Company's tenants or borrowers to satisfy obligations under their respective contractual arrangements with the Company and the potential inability of the Company to enforce its rights under its leases during the pendency of any pandemic;
• the ability and willingness of the Company's tenants to renew their leases with the Company upon expiration of the leases or the Company's ability to reposition its properties on the same or better terms in the event of a nonrenewal or in the event the Company exercises its right to replace an existing tenant;
• fluctuations in reimbursements from third party payors such as Medicare and Medicaid;
• supply and demand for operating properties in the market areas in which the Company operates;
• changes in operating expenses of the Company's properties including, but not limited to, expenditures for property taxes, property and liability insurance premiums, and utility rates;
• the Company's ability and the ability of its tenants to obtain and maintain adequate property, liability and other insurance from reputable, financial stable providers;
• restrictive covenants on certain of the Company's properties subject to ground leases that may restrict or limit the uses of its properties and the types of tenants the Company is able to lease to, and the Company's ability to attract new tenants;
• the impact from damage to the Company's properties from, or increased operating costs associated with, catastrophic weather and other natural events and the physical effect of climate change;
• retention of the Company's senior management team and its ability to attract and retain qualified key personnel;
• legislative and regulatory changes, including changes to laws governing the taxation of real estate investment trusts ("REITs") and changes to laws governing the healthcare industry;
• changes in interest rates, including changes a as result of the potential phasing out of the London Inter-bank Offered Rate ("LIBOR");
• the availability of capital and financing;
• restrictive covenants in the Company's credit facilities;
• changes in the Company's credit ratings;
• HTA's ability to remain qualified as a REIT;
• changes in accounting principles generally accepted in the United States of America, policies and guidelines applicable to REITs; and
• the risk factors set forth in HTA's most recent Annual Report on Form 10-K and in HTA's most recent Quarterly Reports on Form 10-Q.

Forward-looking statements speak only as of the date made.  Except as otherwise required by the federal securities laws, HTA undertakes no obligation to update any forward-looking statements to reflect the events or circumstances arising after the date as of which they are made.  As a result of these risks and uncertainties, readers are cautioned not to place undue reliance on the forward-looking statements included in this press release or that may be made elsewhere from time to time by, or on behalf of, HTA.

Financial Contact:
Robert A. Milligan
Chief Financial Officer
Healthcare Trust of America, Inc.
480.998.3478
RobertMilligan@htareit.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/healthcare-trust-of-america-inc-announces-reactivation-of-its-share-repurchase-program-301136175.html

SOURCE Healthcare Trust of America, Inc.

FAQ

What is the purpose of HTA's stock repurchase program?

The stock repurchase program aims to enhance shareholder value by reducing the number of outstanding shares.

How much stock is HTA authorized to repurchase?

HTA is authorized to repurchase up to $300 million of its Class A common stock.

When does HTA's stock repurchase program expire?

The stock repurchase program is effective until September 22, 2023.

How will HTA finance its stock repurchases?

HTA intends to finance stock repurchases through available cash and its revolving credit facility.